These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 16985626)
1. Advances in the Medical Treatment of Prostate Cancer, Bladder Cancer, Renal Cell Cancer, and Benign Prostatic Hyperplasia: Highlights from the XVIIth Congress of the European Association of Urology, Birmingham, UK, February 23-26, 2002. Seitz C; Remzi M; Djavan B; Roehrborn CG Rev Urol; 2003; 5(2):90-110. PubMed ID: 16985626 [No Abstract] [Full Text] [Related]
2. Urological oncology in Europe. Research highlights from the XVIIth congress of the European Association of Urology, Birmingham, UK, February 23-26, 2002. Thompson E Drugs Today (Barc); 2002 Apr; 38(4):221-34. PubMed ID: 12532191 [No Abstract] [Full Text] [Related]
3. A report from the 27th Annual Congress Of The European Association Of Urology (February 24-28, 2012 - Paris, France). Rabasseda X Drugs Today (Barc); 2012 Mar; 48(3):233-43. PubMed ID: 22462042 [TBL] [Abstract][Full Text] [Related]
4. New Findings in Prostate Cancer, Benign Prostatic Hyperplasia, and Sexual Dysfunction: Highlights from the XVIII Congress of the European Association of Urology, March 12-15, 2003, Madrid, Spain. Remzi M; Djavan B Rev Urol; 2004; 6(1):19-28. PubMed ID: 16985567 [No Abstract] [Full Text] [Related]
5. What's New in Prostate Cancer, Benign Prostatic Hyperplasia, and Minimally Invasive Surgery?: Highlights from the XIXth Congress of the European Association of Urology, March 23-27, 2004, Vienna, Austria. Anagnostou T; Fong YK; Remzi M; Dobrovits M; Kaisary A; Djavan B Rev Urol; 2005; 7(1):18-40. PubMed ID: 16985803 [No Abstract] [Full Text] [Related]
6. Advances in the treatment of lower urinary tract symptoms and benign prostatic hyperplasia: highlights from the 21st European association of urology congress, april 5-8, 2006, paris, france. Roehrborn CG Rev Urol; 2006; 8(4):216-25. PubMed ID: 17192801 [No Abstract] [Full Text] [Related]
7. Forecasting the Future of Urology Practice: A Comprehensive Review of the Recommendations by International and European Associations on Priority Procedures During the COVID-19 Pandemic. Amparore D; Campi R; Checcucci E; Sessa F; Pecoraro A; Minervini A; Fiori C; Ficarra V; Novara G; Serni S; Porpiglia F Eur Urol Focus; 2020 Sep; 6(5):1032-1048. PubMed ID: 32553544 [TBL] [Abstract][Full Text] [Related]
8. A report from the 28th Annual European Association of Urology Congress (March 3-7, 2013 - Milan, Italy). Rabasseda X Drugs Today (Barc); 2013 Apr; 49(4):271-82. PubMed ID: 23616954 [TBL] [Abstract][Full Text] [Related]
9. New findings in benign prostatic hyperplasia and incontinence: highlights from the 26th annual congress of the European association of urology, march 18-22, 2011, vienna, austria. Herout R; Farr A; Sevcenco S; Kazzazi A; Djavan B Rev Urol; 2011; 13(2):112-7. PubMed ID: 21935344 [No Abstract] [Full Text] [Related]
10. Report from the XVIIth Congress of the European Society of Cardiology, Birmingham, UK, 25-29 August 1996. Purcell H Br J Clin Pract; 1996; 50(7):354-6. PubMed ID: 9015904 [No Abstract] [Full Text] [Related]
11. A report from the 29th Annual Congress of the European Association of Urology (April 11-15 - Stockholm, Sweden). Rabasseda X Drugs Today (Barc); 2014 May; 50(5):385-95. PubMed ID: 24918838 [TBL] [Abstract][Full Text] [Related]
12. Benign prostatic hyperplasia evaluation and management by urologists and primary care physicians: practice patterns from the observational BPH registry. Wei JT; Miner MM; Steers WD; Rosen RC; Seftel AD; Pasta DJ; Carman WJ; Roehrborn CG; J Urol; 2011 Sep; 186(3):971-6. PubMed ID: 21791352 [TBL] [Abstract][Full Text] [Related]
13. Contentious controversies: a report from the 3rd World Congress on Controversies in Urology (February 25-28, 2010, Athens, Greece). Rabasseda X Drugs Today (Barc); 2010 Apr; 46(4):291-6. PubMed ID: 20502726 [TBL] [Abstract][Full Text] [Related]
14. 1997 American Urological Association Gallup survey: Changes in diagnosis and management of prostate cancer and benign prostatic hyperplasia, and other practice trends from 1994 to 1997. Gee WF; Holtgrewe HL; Blute ML; Miles BJ; Naslund MJ; Nellans RE; O'Leary MP; Thomas R; Painter MR; Meyer JJ; Rohner TJ; Cooper TP; Blizzard R; Fenninger RB; Emmons L J Urol; 1998 Nov; 160(5):1804-7. PubMed ID: 9783961 [TBL] [Abstract][Full Text] [Related]
15. New findings in bladder and prostate cancer: highlights from the 26th annual congress of the European Association of Urology, March 18-22, 2011, Vienna, Austria. Farr A; Herout R; Margreiter M; Tosev G; Djavan B Can J Urol; 2011 Apr; 18(2):5601-7. PubMed ID: 21504647 [TBL] [Abstract][Full Text] [Related]
16. Risk factors for urethral stricture and/or bladder neck contracture after monopolar transurethral resection of the prostate for benign prostatic hyperplasia. Grechenkov A; Sukhanov R; Bezrukov E; Butnaru D; Barbagli G; Vasyutin I; Tivtikyan A; Rapoport L; Alyaev Y; Glybochko P Urologia; 2018 Nov; 85(4):150-157. PubMed ID: 30426880 [TBL] [Abstract][Full Text] [Related]
17. Resistive index of prostate capsular arteries: a newly identified parameter to diagnose and assess bladder outlet obstruction in patients with benign prostatic hyperplasia. Zhang X; Li G; Wei X; Mo X; Hu L; Zha Y; Hou J J Urol; 2012 Sep; 188(3):881-7. PubMed ID: 22819411 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Ho:Yag laser and pneumatic lithotripsy combined with transurethral prostatectomy in high burden bladder stones with benign prostatic hyperplasia. Ercil H; Altunkol A; Alma E; Goren MR; Sener NC; Kuyucu F; Karakoyunlu AN; Vuruskan E; Ortoglu F; Gurbuz ZG Asian J Surg; 2016 Oct; 39(4):238-42. PubMed ID: 25937584 [TBL] [Abstract][Full Text] [Related]
19. New findings in bladder and prostate cancer: highlights of the 22nd annual congress of the European association of urology, march 21-24, 2007, berlin, Germany. Rom M; Kuehhas FE; Djavan B Rev Urol; 2007; 9(4):214-9. PubMed ID: 18231618 [No Abstract] [Full Text] [Related]
20. Acute urinary tract infection in patients with underlying benign prostatic hyperplasia and prostate cancer. Tolani MA; Suleiman A; Awaisu M; Abdulaziz MM; Lawal AT; Bello A Pan Afr Med J; 2020; 36():169. PubMed ID: 32952813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]